Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

被引：0
|
作者：
Huang, H. T. [1 ]
Hawkins, M. A. [1 ,2 ]
Fenwick, J. D. [3 ,4 ]
Nix, M. G. [5 ]
机构：
[1] UCL, Dept Med Phys & Biomed Engn, London, England
[2] CRUK RadNet City London, London, England
[3] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[4] Clatterbridge Canc Ctr, Dept Phys, Wirral, Merseyside, England
[5] Leeds Teaching Hosp NHS Trust, Dept Med Phys & Engn, Leeds, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页码：E375 / E375
页数：1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [2] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [3] Concurrent chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer
    Song, X
    Gallant, V
    Laurie, S
    Nicholas, G
    Reaume, N
    MacRae, R
    Agboola, O
    Perry, G
    Lochrin, C
    Goss, G
    LUNG CANCER, 2005, 49 : S174 - S175
  • [4] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Sonam Puri
    Michael Shafique
    Jhanelle E. Gray
    Current Treatment Options in Oncology, 2018, 19
  • [5] Current topics of immune checkpoint inhibitors in perioperative and locally advanced non-small cell lung cancer
    Horinouchi, Hidehito
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer
    Puri, Sonam
    Shafique, Michael
    Gray, Jhanelle E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [7] Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Lin, Gen
    Wang, Zhijie
    Chu, Qian
    Hu, Yi
    Huang, Dingzhi
    Wang, Jun
    Yang, Fan
    Zhong, Wenzhao
    Zhou, Chengzhi
    Zhu, Bo
    Ai, Xinghao
    Cao, Baoshan
    Cao, Yabing
    Chen, Mingqiu
    Chen, Xiaohui
    Chu, Tianqing
    Duan, Jianchun
    Fan, Yun
    Fang, Yong
    Feng, Shuitu
    Feng, Weineng
    Guo, Hui
    Han, Chengbo
    He, Yong
    Hong, Shaodong
    Hu, Jie
    Huang, Meijuan
    Huang, Yan
    Jiang, Da
    Jiang, Kan
    Jiang, Richeng
    Jin, Bo
    Jin, Shi
    Li, Jisheng
    Li, Min
    Li, Ziming
    Li, Chao
    Lin, Jie
    Liu, Anwen
    Liu, Si-Yang Maggie
    Yutao, Liu
    Liu, Zhefeng
    Liu, Zhe
    Liu, Zhenhua
    Liu, Zhentian
    Liu, Zhigang
    Lu, Yuping
    Lv, Tangfeng
    Ma, Zhiyong
    Miao, Qian
    THORACIC CANCER, 2024, 15 (05) : 419 - 426
  • [8] The role of immune checkpoint inhibitors in advanced non-small cell lung cancer
    Pistamaltzian, Nikolaos F.
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 435 - 447
  • [9] Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Erkan Topkan
    Cem Parlak
    Savas Topuk
    Berrin Pehlivan
    BMC Cancer, 12
  • [10] Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
    Topkan, Erkan
    Parlak, Cem
    Topuk, Savas
    Pehlivan, Berrin
    BMC CANCER, 2012, 12
12345